Concepedia

Jagath R. Junutula

JR

Statistics

Publications

50

Citations

6.9K

H-Index

39

Active since

1997

Affiliations

Garvan Institute of Medical Research(Current)

UNSW Sydney

Stanford University

Indian Institute of Science Bangalore

University of Colorado Health

Jagath R. Junutula is an author at Garvan Institute of Medical Research specializing in life sciences, molecular biology, and pharmacy.

ORCID

Publications per year

1997–2021

50

Publications

50

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

Jagath R. Junutula, Helga Raab, Suzanna Clark et al. · Nature Biotechnology · 2008 · 1.4K citations

, , +16

Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates

Ben‐Quan Shen, Keyang Xu, Luna Liu et al. · Nature Biotechnology · 2012 · 999 citations

, , +17

Characterization of the Role of the Rab GTPase-activating Protein AS160 in Insulin-regulated GLUT4 Trafficking

Mark Larance, Georg Ramm, Jacqueline Stöckli et al. · Journal of Biological Chemistry · 2005 · 390 citations · Full text

, , +17

Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Jagath R. Junutula, Kelly M. Flagella, Richard Graham et al. · Clinical Cancer Research · 2010 · 292 citations

, , +17

Therapeutic potential of an anti-CD79b antibody–drug conjugate, anti–CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma

David Dornan, Fiona Bennett, Yvonne Chen et al. · Blood · 2009 · 271 citations · Full text

, , +17

1–5 of 50